These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38888584)

  • 1. Successful Desensitization to Isatuximab in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis. Reply to: Anaphylactic Shock due to Isatuximab and Successful Desensitization.
    Hutten EM; Roeloffzen WW; Lambeck AJ; van den Born-Bondt T; Oude Elberink HN; van de Ven AAJ
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):214-216. PubMed ID: 38888584
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis.
    Torres Górriz MC; Borrás Cuartero J; Pesántez Méndez CG; Stein Coronado CI; Enrique E
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):216-217. PubMed ID: 38275249
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylactic Shock due to Isatuximab and Successful Desensitization.
    Torres Górriz MC; Borrás Cuartero J; Germán Sánchez A; Pesántez Méndez CG; Stein Coronado CI; Fernández-Delgado M; Beltrán Agost S; Enrique E
    J Investig Allergol Clin Immunol; 2024 Jun; 34(3):200-202. PubMed ID: 37812194
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization.
    Kim KW; Chung S; Lee SY; Yoon SS; Kang HR
    J Investig Allergol Clin Immunol; 2020; 30(6):457-459. PubMed ID: 32376522
    [No Abstract]   [Full Text] [Related]  

  • 5. Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.
    Kibsgaard L; Skjold T; Deleuran M; Vestergaard C
    Acta Derm Venereol; 2014 May; 94(3):363-4. PubMed ID: 24162824
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
    González-de-Olano D; Morgado JM; Juárez-Guerrero R; Sánchez-Muñoz L; Letellez-Fernández J; Malón-Giménez D; Castells MC
    J Allergy Clin Immunol Pract; 2016; 4(2):338-40. PubMed ID: 26725157
    [No Abstract]   [Full Text] [Related]  

  • 7. Unraveling wasp sensitization in a patient with systemic mastocytosis by CAP-inhibition assay.
    Valero H; Luengo O; Cardona V; Pereira J; Labrador-Horrillo M
    Allergol Immunopathol (Madr); 2024; 52(5):85-88. PubMed ID: 39278856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-emptive Evaluation of Venom Allergy in a Patient with Systemic Mastocytosis.
    Gülen T; Akin C
    Acta Derm Venereol; 2018 Jan; 98(1):149-150. PubMed ID: 28902950
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of ultra-rush protocols for hymenoptera venom immunotherapy in systemic mastocytosis.
    Gruzelle V; Ramassamy M; Bulai Lidiveanu C; Didier A; Mailhol C; Guilleminault L
    Allergy; 2018 Nov; 73(11):2260-2263. PubMed ID: 29984458
    [No Abstract]   [Full Text] [Related]  

  • 10. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
    Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
    Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.
    Gonzalez-Diaz SN; Villarreal-Gonzalez RV; De Lira-Quezada CE; Rocha-Silva GK; Oyervides-Juarez VM; Vidal-Gutierrez O
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):265-267. PubMed ID: 32856592
    [No Abstract]   [Full Text] [Related]  

  • 12. α-Gal-a new clue for anaphylaxis in mastocytosis.
    Roenneberg S; Böhner A; Brockow K; Arnold A; Darsow U; Eberlein B; Biedermann T
    J Allergy Clin Immunol Pract; 2016; 4(3):531-2. PubMed ID: 26795642
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients.
    Vos BJPR; van Anrooij B; van Doormaal JJ; Dubois AEJ; Oude Elberink JNG
    J Allergy Clin Immunol Pract; 2017; 5(5):1264-1271. PubMed ID: 28499778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful desensitization protocol for a patient with fludarabine anaphylaxis during hematopoietic transplantation.
    Xu M; AlRiyami L; Rao H; Hook R; Wall DA; Schechter T; Grunebaum E
    Pediatr Allergy Immunol; 2022 Jun; 33(6):e13789. PubMed ID: 35754132
    [No Abstract]   [Full Text] [Related]  

  • 16. IgE-mediated anaphylaxis to methylprednisolone succinate in a patient with indolent systemic mastocytosis.
    Van Mieghem E; Beyens M; Van Gasse AL; Verlinden A; Ebo DG; Sabato V
    Allergol Int; 2022 Oct; 71(4):552-554. PubMed ID: 35817697
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic mastocytosis with recurrent anaphylactic shock and multiple organ dysfunction failure.
    Chen G; Chen L; Qin X; Xie X; Li G; Xu B
    Clin Lab; 2015; 61(1-2):179-82. PubMed ID: 25807653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization to lenalidomide in a patient with relapsed multiple myeloma.
    Seki JT; Banglawala S; Lentz EM; Reece DE
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):162-5. PubMed ID: 23103087
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy.
    Jakubovic BD; Jagdis A; Trinkaus M; Lang A; Chang A; Rastin T; Castells M; Betschel S
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):780-782. PubMed ID: 31415904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anaphylactoid reaction in occult systemic mastocytosis. A rare dermatologic emergency ].
    Ständer H; Beier K; Metze D; Brehler R
    Hautarzt; 2005 Mar; 56(3):265-9. PubMed ID: 15619082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.